What to Expect from Mounjaro Withdrawal

The day you give yourself the last pen

Picture the week after your final injection. Nothing dramatic happens. You will not feel a crash, shaking hands or the kind of rebound that follows stopping certain other medicines. Tirzepatide has a half-life of roughly five days, so it clears slowly, drug levels taper over two to three weeks naturally, even if you stop all at once.

What tends to shift first is appetite. The GIP and GLP-1 receptor activity that was quietly suppressing hunger fades with the medicine. Many people describe feeling noticeably hungrier within two to three weeks of their last dose, sometimes returning to a level they had not felt since before treatment started. That is not a sign that something is wrong. It is the body's own signalling reasserting itself once the medicine is gone.

One misconception worth gently correcting: stopping Mounjaro does not cause nausea, shaking or sweats in the way that stopping certain other medicines might. The gastrointestinal side effects that can accompany the early weeks of treatment tend to resolve as the medicine leaves the system, not worsen. If you do feel unwell in an unusual way after stopping, that deserves a conversation with your prescriber rather than an assumption that it is "withdrawal."

The NHS medicines page for tirzepatide covers what to expect when stopping the medicine and is worth reading before you make any decision.

Weight regain: what the evidence actually says about stopping tirzepatide

This is the part most people are genuinely asking about when they search for tirzepatide withdrawal. The clinical trial evidence is clear and worth knowing up front. In the SURMOUNT-1 extension study, participants who stopped tirzepatide after 36 weeks regained a substantial portion of the weight they had lost over the following year, while those who continued lost more. Weight is not simply locked in by the medicine, it is managed by it, for as long as you take it.

That does not mean stopping is the wrong choice for everyone. People stop for all sorts of reasons: planned surgery, pregnancy plans, a change in health circumstances, or simply reaching a point where they and their prescriber agree that lifestyle changes can carry them forward. The variable is whether there is a plan in place when treatment ends.

If you have been on tirzepatide for some time, our page on what to expect as Mounjaro leaves your system goes into more clinical depth on the symptom picture. And if cost has been a factor in your decision to stop, the context around Eli Lilly's UK pricing changes may be useful background.

The honest summary: weight regain after stopping is common, often gradual, and not inevitable if the right support is in place. It is not a failure of willpower. The biology shifts when the medicine stops, that is why clinical guidance consistently recommends stopping only with a clear aftercare plan.

Practical considerations if you are thinking about stopping

The most useful thing you can do before stopping is talk to a prescriber. Not because it is dangerous to stop, but because the decision changes depending on how long you have been on treatment, which dose you are on, what your weight-related conditions are, and what lifestyle infrastructure exists around the medicine.

A few specifics worth knowing. If you are on tirzepatide and using oral contraceptives, there are absorption considerations worth discussing with your prescriber before you change treatment, our page on Mounjaro and HRT covers related hormonal interactions. If you are stopping because you are planning to conceive, the prescriber will want to plan a wash-out period before you try. Tirzepatide is not recommended during pregnancy or while breastfeeding.

For some people, the question is not whether to stop but whether to pause. A short break (for surgery, for example) is managed differently from a planned long-term discontinuation. People considering surgery should tell their anaesthetist and surgical team they are on or recently stopped a GLP-1 medicine, our main Mounjaro page has more on managing treatment around procedures. If you are also planning to travel during or after your course of treatment, our guidance on flying with Mounjaro covers what you need to know about taking the medicine on a plane.

If you are on a multipack supply and want to understand how your remaining doses fit into a stopping plan, our multipack information page explains how pens and supply periods work. Practically, there is no need to waste doses, and tapering is not a clinically required step, but pacing any lifestyle changes to coincide with the end of treatment is sensible.

Finally, a note on restarting. Stopping Mounjaro does not permanently alter how your body responds to it. People who restart after a break generally retitrate from the starting dose, and clinical response is typically re-established. Your prescriber will review your situation fresh before any new course begins. At nume, that review happens the same day a consultation is submitted, by a GPhC-registered Independent Prescriber, not an automated system. If you are considering whether treatment is right for you at all, the free consultation is the right starting point.